We are live on
!
Find out more
BCIM
British Columbia Investment Management Portfolio holdings
AUM
$16B
1-Year Est. Return
37.57%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+37.57%
3 Year Est. Return
+108.64%
5 Year Est. Return
+130.92%
10 Year Est. Return
+502.53%
AUM
$11.1B
AUM Growth
-$1.04B
(-8.6%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-10.03%
Top 10 Holdings %
Top 10 Hldgs %
15.54%
Holding
812
New
29
Increased
252
Reduced
388
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$27.8M |
| 3 |
Medtronic
MDT
|
+$17.5M |
| 4 |
General Motors
GM
|
+$14.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$78M |
| 2 |
Canadian National Railway
CNI
|
+$41.5M |
| 3 |
Brookfield
BN
|
+$40M |
| 4 |
Suncor Energy
SU
|
+$37.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.55% |
| 2 | Technology | 15.47% |
| 3 | Financials | 14.56% |
| 4 | Industrials | 10.27% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Medtronic
MDT
$116B
| $77.9M | 0.7% |
998,937
+231,267
| +30% | +$17.5M |
|
27
Coca-Cola
KO
$376B
| $76.6M | 0.69% |
1,889,617
+287,484
| +18% | +$12M |
|
28
Cisco
CSCO
$447B
| $76.4M | 0.69% |
2,777,366
-927,845
| -25% | -$26.1M |
|
29
Home Depot
HD
$341B
| $73.2M | 0.66% |
643,945
-39,126
| -6% | -$4.32M |
|
30
Amazon
AMZN
$2.86T
| $72.3M | 0.65% |
3,885,320
+560
| +0% | +$9.85K |
|
31
Visa
V
$682B
| $71.5M | 0.65% |
1,092,519
-35,241
| -3% | -$2.33M |
|
32
Comcast
CMCSA
$92.9B
| $70M | 0.63% |
2,479,078
-162,530
| -6% | -$4.67M |
|
33
Qualcomm
QCOM
$173B
| $70M | 0.63% |
1,009,390
-174,252
| -15% | -$12.3M |
|
34
Walmart Inc
WMT
$921B
| $68M | 0.61% |
2,479,767
+13,230
| +0.5% | +$375K |
|
35
AT&T
T
$168B
| $67.1M | 0.61% |
2,721,148
-824,218
| -23% | -$20.9M |
|
36
3M
MMM
$94.2B
| $66.9M | 0.6% |
485,299
-97,399
| -17% | -$13.4M |
|
37
Biogen
BIIB
$31.1B
| $65M | 0.59% |
154,027
-35,357
| -19% | -$13.9M |
|
38
Mastercard
MA
$497B
| $64.8M | 0.59% |
750,633
+144,054
| +24% | +$12.5M |
|
39
CVS Health
CVS
$121B
| $63.5M | 0.57% |
615,667
-19,022
| -3% | -$1.92M |
|
40
Bristol-Myers Squibb
BMY
$132B
| $63.2M | 0.57% |
980,327
-261,714
| -21% | -$16.4M |
|
41
Philip Morris
PM
$294B
| $63M | 0.57% |
836,171
+108,882
| +15% | +$8.84M |
|
42
UnitedHealth
UNH
$358B
| $61.4M | 0.55% |
519,258
+454
| +0.1% | +$50.4K |
|
43
Union Pacific
UNP
$177B
| $60.8M | 0.55% |
561,054
+4,972
| +0.9% | +$583K |
|
|
CERN
44
DELISTED
Cerner Corp
CERN
| $57.4M | 0.52% |
783,402
-174,705
| -18% | -$12.1M |
|
45
McDonald's
MCD
$193B
| $55.1M | 0.5% |
565,828
-31,170
| -5% | -$2.96M |
|
46
Altria Group
MO
$109B
| $52.2M | 0.47% |
1,043,525
+204,457
| +24% | +$10.9M |
|
47
Nike
NKE
$61.2B
| $50.9M | 0.46% |
1,014,948
-115,190
| -10% | -$5.51M |
|
48
Boeing
BA
$182B
| $50.6M | 0.46% |
337,311
-14,266
| -4% | -$2.08M |
|
49
SLB Ltd
SLB
$77.3B
| $50M | 0.45% |
599,205
-64,357
| -10% | -$5.36M |
|
50
US Bancorp
USB
$102B
| $49.9M | 0.45% |
1,142,456
-96,938
| -8% | -$4.25M |
|
Similar funds
MG
CLGM
LCOV
UCFA
EF
EH
NMO
British Columbia Investment Management's Q1 2015 Portfolio in Review
As of Q1 2015, British Columbia Investment Management held 812 positions worth $11.1B, down 8.6% from $12.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
British Columbia Investment Management withdrew a net $1.11B in Q1 2015, closing 99 positions and reducing 388 holdings. Its most notable exit was Allergan Inc, an estimated $78M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, British Columbia Investment Management opened a new position in Stratasys worth $2.64M.
- British Columbia Investment Management's largest Q1 2015 buy was Stratasys: 50,000 shares worth $2.64M.
- British Columbia Investment Management added most to Allergan plc in Q1 2015, an estimated $47M increase.
- British Columbia Investment Management's biggest Q1 2015 reduction was Canadian National Railway, cutting an estimated $41.5M.
- British Columbia Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $78M.
- British Columbia Investment Management's ten largest holdings make up 16% of its $11.1B portfolio in Q1 2015.
- British Columbia Investment Management opened 29 new positions and closed 99 in Q1 2015.
- British Columbia Investment Management's portfolio value fell 8.6% quarter-over-quarter to $11.1B.
Based on British Columbia Investment Management's 13F filing for Q1 2015, filed 5 May 2015.